v3.25.1
SUPPLEMENTAL FINANCIAL INFORMATION
 3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SUPPLEMENTAL FINANCIAL INFORMATION SUPPLEMENTAL FINANCIAL INFORMATION
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.
As of
March 31, 2025December 31, 2024
Cash and cash equivalents
$2,454 $2,874 
Short-term restricted cash19 16 
Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position
2,473 2,889 
Long-term restricted cash(1)
3 3 
Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows
$2,476 $2,893 
(1) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.

INVENTORIES.
As of
March 31, 2025December 31, 2024
Raw materials$991 $921 
Work in process99 92 
Finished goods1,068 926 
Inventories
$2,158 $1,939 

Certain inventory items are long-term in nature and therefore have been recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position and are not reflected in the table above. See the supplemental table “All Other Non-Current Assets” for further information.

PROPERTY, PLANT, AND EQUIPMENT – NET.
As of
March 31, 2025December 31, 2024
Land and improvements
$146 $66 
Buildings, structures, and related equipment
2,107 1,943 
Machinery and equipment
2,905 2,705 
Leasehold improvements and manufacturing plants under construction
503 553 
Total property, plant, and equipment, at original cost
5,661 5,267 
Accumulated depreciation
(3,179)(3,080)
Right-of-use operating lease assets, net of amortization
369 364 
Property, plant, and equipment – net
$2,851 $2,550 

ALL OTHER ASSETS AND ALL OTHER LIABILITIES.

All Other Current Assets
As of
March 31, 2025December 31, 2024
Prepaid expenses and deferred costs
$249 $188 
Financing receivables – net
90 90 
Derivative instruments(1)
100 123 
Tax receivables
116 115 
Other(2)
46 16 
All other current assets
$601 $532 

All Other Non-Current Assets
As of
March 31, 2025December 31, 2024
Prepaid pension asset
$723 $657 
Equity method and other investments
235 373 
Financing receivables – net
186 183 
Long-term receivables – net
161 142 
Inventories
143 139 
Contract and other deferred assets
213 208 
Capitalized cloud computing arrangement implementation costs113 84 
Other(3)
152 164 
All other non-current assets
$1,926 $1,950 

All Other Current Liabilities
As of
March 31, 2025December 31, 2024
Sales allowances and related liabilities
$221 $242 
Income and indirect tax liabilities including uncertain tax positions
286 279 
Product warranties
171 168 
Accrued freight and utilities
154 163 
Operating lease liabilities
119 115 
Derivative instruments(1)
120 90 
Interest payable on borrowings
141 92 
Environmental and asset retirement obligations
17 17 
Other(4)
355 386 
All other current liabilities
$1,583 $1,552 
All Other Non-Current Liabilities
As of
March 31, 2025December 31, 2024
Contract liabilities
$724 $686 
Operating lease liabilities266 270 
Environmental and asset retirement obligations395 291 
Income and indirect tax liabilities including uncertain tax positions
170 237 
Derivative instruments(1)
39 64 
Finance lease obligations
40 40 
Sales allowances and related liabilities
24 23 
Other(5)
182 184 
All other non-current liabilities
$1,840 $1,796 
(1) Derivative instruments include the related accrued interest. Refer to Note 12, “Financial Instruments and Fair Value Measurements” for further information.
(2) Current assets Other primarily represents indemnity assets associated with separation agreements with GE as of March 31, 2025.
(3) Non-current assets Other primarily consists of indemnity assets associated with separation agreements with GE, derivative instruments, and tax receivables.
(4) Current liabilities Other primarily consists of miscellaneous accrued costs, contingent consideration liabilities, and dividends payable to stockholders.
(5) Non-current liabilities Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.

SUPPLY CHAIN FINANCE PROGRAMS.

The Company participates in voluntary supply chain finance programs which provide participating suppliers the opportunity to sell their GE HealthCare receivables to third parties at the sole discretion of both the suppliers and the third parties. We evaluate supply chain finance programs to ensure the use of a third-party intermediary to settle our trade payables does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables to borrowings. In connection with the supply chain finance programs, payment terms normally range from 30 to 180 days, depending on the underlying supplier agreements.

Included within Accounts payable in the Condensed Consolidated Statements of Financial Position as of March 31, 2025 and December 31, 2024 were $364 million and $394 million, respectively, of confirmed supplier invoices that are outstanding and subject to third-party programs.

REDEEMABLE NONCONTROLLING INTERESTS.

The Company has noncontrolling interests with redemption features. These redemption features, such as put options, could require the Company to purchase the noncontrolling interests upon the occurrence of certain events. All noncontrolling interests with redemption features that are not solely within our control are recognized within the Condensed Consolidated Statements of Financial Position between liabilities and equity. Redeemable noncontrolling interests are initially recorded at the issuance date fair value. Those that are currently redeemable, or probable of becoming redeemable, are subsequently adjusted to the greater of current redemption value or initial carrying value.

Activity attributable to redeemable noncontrolling interests is presented below.
For the three months ended March 31
20252024
Balance at beginning of period$188 $165 
Net income attributable to redeemable noncontrolling interests
24 11 
Balance at end of period $211 $177 
OTHER INCOME (EXPENSE) – NET.
For the three months ended March 31
20252024
Net financing income and investment income (loss)
$(1)$(16)
Equity method income (loss)
3 1 
Change in fair value of assumed obligations
(8)(8)
Gain on remeasurement of NMP equity method investment(1)
97 — 
Other items, net(2)
8 14 
Total other income (expense) – net
$99 $(8)
(1) Refer to Note 7, “Acquisitions, Goodwill, and Other Intangible Assets” for additional information on the NMP acquisition.
(2) Other items, net primarily consists of licensing and royalty income, lease income, change in tax indemnities, and gains and losses related to derivatives. Additionally, for the three months ended March 31, 2025 it includes a realization of a gain contingency.